MELISSA ROWLAND: Open Payments
NPI 1265434088 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 31 payments from 12 companies in 2025. Trend: 2023 $655 · 2024 $1,028 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $214 |
| CVRx, Inc. | 4 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Stryker Corporation | 1 | $58 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Amgen Inc. | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: Barostim Neo System, LEQVIO, Ozempic, Wegovy, Kerendia, FLOWTRIEVER CATHETER, S, VERQUVO, JARDIANCE.
Industry payments across SC — which companies pay providers there.
